As of Feb 27
| +0.285 / +1.94%|
The 6 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 24.00, with a high estimate of 28.00 and a low estimate of 18.00. The median estimate represents a +60.05% increase from the last price of 15.00.
The current consensus among 6 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.